APA (7th ed.) Citation

ND, F., TM, C., C, M., LB, S., ZD, G., EC, W., . . . JE, E. (2011). Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. Alimentary pharmacology & therapeutics, 33(1), 127. https://doi.org/10.1111/j.1365-2036.2010.04503.x

Chicago Style (17th ed.) Citation

ND, Freedman, Curto TM, Morishima C, Seeff LB, Goodman ZD, Wright EC, Sinha R, and Everhart JE. "Silymarin Use and Liver Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial." Alimentary Pharmacology & Therapeutics 33, no. 1 (2011): 127. https://doi.org/10.1111/j.1365-2036.2010.04503.x.

MLA (9th ed.) Citation

ND, Freedman, et al. "Silymarin Use and Liver Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial." Alimentary Pharmacology & Therapeutics, vol. 33, no. 1, 2011, p. 127, https://doi.org/10.1111/j.1365-2036.2010.04503.x.